Demonstrating Pharmaceutical Quality System Effectiveness and Driving Continual Improvement: Evidence-Based Risk Reduction
Related Experiment Video
Updated: Feb 11, 2026

Continuous Hydrologic and Water Quality Monitoring of Vernal Ponds
Published on: November 13, 2017
Emma Ramnarine1, Kevin O'Donnell2
1Sr. Director, Head Global Analytical Science and Technology, Genentech/Roche eramnar@gene.com.
Abstract:
Product knowledge grows and evolves during the life of a product. In order to maintain a state of control and deliver product with consistent quality throughout its commercial life, continuous improvement and product lifecycle management become essential. The practical link between product and process knowledge, risk-based control strategies, and continual improvement and innovation can be made stronger through evidence-based risk reduction. This paper introduces the concept of evidence-based risk reduction within the continual improvement framework. It presents how regulatory relief and flexibility in post-approval change management and overall product lifecycle management can likely only be achieved via (1) effective application of science and risk-based concepts and (2) demonstrated effectiveness of the pharmaceutical quality system in assuring a state of control.
Related Concept Videos
Drive-Reduction Theory: Push Theory of Motivation
The Evidence for Evolution
Pharmaceutical Equivalents
Oxidation-Reduction Reactions
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...
Relative Risk

